Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel F Hayes

Showing results (171-180 of 336) with videos related to

Pageof 34
Sort By:
Breast Cancer Research and Treatment|June 24, 2017
Variable aromatase inhibitor plasma concentrations do not correlate with circulating estrogen concentrations in post-menopausal breast cancer patientsDaniel L Hertz, Kelly A Speth, Kelley M Kidwell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2019
Circulating Tumor Cell Clusters in Patients with Metastatic Breast Cancer: a SWOG S0500 Translational Medicine StudyCostanza Paoletti, Jieling Miao, Emily M Dolce, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2012
Predictors of aromatase inhibitor discontinuation as a result of treatment-emergent symptoms in early-stage breast cancerN Lynn Henry, Faouzi Azzouz, Zereunesay Desta, et al.
British Journal of Cancer|January 16, 2020
Tumour-derived extracellular vesicles in blood of metastatic cancer patients associate with overall survivalAfroditi Nanou, M Craig Miller, Leonie L Zeune, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 20, 2008
Estrogen receptor genotypes influence hot flash prevalence and composite score before and after tamoxifen therapyYan Jin, Daniel F Hayes, Lang Li, et al.
Breast Cancer Research and Treatment|August 1, 2016
Phase II studies of two different schedules of dasatinib in bone metastasis predominant metastatic breast cancer: SWOG S0622Anne F Schott, William E Barlow, Catherine H Van Poznak, et al.
Breast Cancer Research : BCR|November 30, 2006
Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: results from CALGB 9342Lyndsay N Harris, Gloria Broadwater, Nancy U Lin, et al.
Pharmacogenetics and Genomics|June 7, 2021
Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activityDaniel L Hertz, Julie A Douglas, Kelley M Kidwell, et al.
Oral Diseases|December 4, 2020
Osteonecrosis of the jaw risk factors in bisphosphonate-treated patients with metastatic cancerCatherine Van Poznak, Evan L Reynolds, Cherry L Estilo, et al.
Breast Cancer Research and Treatment|March 29, 2011
Women's interest in taking tamoxifen and raloxifene for breast cancer prevention: response to a tailored decision aidAngela Fagerlin, Amanda J Dillard, Dylan M Smith, et al.
Pageof 34

Showing results (171-180 of 336) with videos related to

Sort By:
Pageof 34
Breast Cancer Research and Treatment|June 24, 2017
Variable aromatase inhibitor plasma concentrations do not correlate with circulating estrogen concentrations in post-menopausal breast cancer patientsDaniel L Hertz, Kelly A Speth, Kelley M Kidwell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2019
Circulating Tumor Cell Clusters in Patients with Metastatic Breast Cancer: a SWOG S0500 Translational Medicine StudyCostanza Paoletti, Jieling Miao, Emily M Dolce, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2012
Predictors of aromatase inhibitor discontinuation as a result of treatment-emergent symptoms in early-stage breast cancerN Lynn Henry, Faouzi Azzouz, Zereunesay Desta, et al.
British Journal of Cancer|January 16, 2020
Tumour-derived extracellular vesicles in blood of metastatic cancer patients associate with overall survivalAfroditi Nanou, M Craig Miller, Leonie L Zeune, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 20, 2008
Estrogen receptor genotypes influence hot flash prevalence and composite score before and after tamoxifen therapyYan Jin, Daniel F Hayes, Lang Li, et al.
Breast Cancer Research and Treatment|August 1, 2016
Phase II studies of two different schedules of dasatinib in bone metastasis predominant metastatic breast cancer: SWOG S0622Anne F Schott, William E Barlow, Catherine H Van Poznak, et al.
Breast Cancer Research : BCR|November 30, 2006
Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: results from CALGB 9342Lyndsay N Harris, Gloria Broadwater, Nancy U Lin, et al.
Pharmacogenetics and Genomics|June 7, 2021
Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activityDaniel L Hertz, Julie A Douglas, Kelley M Kidwell, et al.
Oral Diseases|December 4, 2020
Osteonecrosis of the jaw risk factors in bisphosphonate-treated patients with metastatic cancerCatherine Van Poznak, Evan L Reynolds, Cherry L Estilo, et al.
Breast Cancer Research and Treatment|March 29, 2011
Women's interest in taking tamoxifen and raloxifene for breast cancer prevention: response to a tailored decision aidAngela Fagerlin, Amanda J Dillard, Dylan M Smith, et al.
Pageof 34